Global Viral Safety Testing Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI08252627

Publication Date:

August 5, 2025

Pages:

120

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

According to this study, the global Viral Safety Testing market size will reach US$ 2148 million by 2031.
Viral safety testing is a critical set of procedures used to detect, quantify, and eliminate the presence of viruses in biological products, especially those intended for human use such as biopharmaceuticals, vaccines, blood products, and gene or cell therapies. This testing ensures that such products are free from contaminating or adventitious viruses, thereby safeguarding patient health and ensuring compliance with regulatory standards.
United States market for Viral Safety Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Viral Safety Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Viral Safety Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Viral Safety Testing players cover Charles River, Eurofins BioPharma, Clean Cells, Texcell, Merck Millipore, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淰iral Safety Testing Industry Forecast鈥� looks at past sales and reviews total world Viral Safety Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Viral Safety Testing sales for 2025 through 2031. With Viral Safety Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Safety Testing industry.
This Insight Report provides a comprehensive analysis of the global Viral Safety Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Safety Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Viral Safety Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Safety Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Safety Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Safety Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Adventitious Virus Tests
Antibody Production Tests
Retrovirus Tests
Specific Virus Tests
Segmentation by Application:
Biopharmaceuticals
Medical Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Eurofins BioPharma
Clean Cells
Texcell
Merck Millipore
Syngene
CPHI Online
Nelson Labs
Sartorius Stedim BioOutsource Limited
WuXi Biologics
ViSpot Co., Ltd.
Syngene International Ltd.
Laboratory Corporation of America Holdings
Creative Biogene
Asahi Kasei Corporation

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Viral Safety Testing Market Size (2020-2031)
2.1.2 Viral Safety Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Viral Safety Testing by Country/Region (2020, 2024 & 2031)
2.2 Viral Safety Testing Segment by Type
2.2.1 Adventitious Virus Tests
2.2.2 Antibody Production Tests
2.2.3 Retrovirus Tests
2.2.4 Specific Virus Tests
2.3 Viral Safety Testing Market Size by Type
2.3.1 Viral Safety Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Viral Safety Testing Market Size Market Share by Type (2020-2025)
2.4 Viral Safety Testing Segment by Application
2.4.1 Biopharmaceuticals
2.4.2 Medical Industry
2.4.3 Others
2.5 Viral Safety Testing Market Size by Application
2.5.1 Viral Safety Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Viral Safety Testing Market Size Market Share by Application (2020-2025)
3 Viral Safety Testing Market Size by Player
3.1 Viral Safety Testing Market Size Market Share by Player
3.1.1 Global Viral Safety Testing Revenue by Player (2020-2025)
3.1.2 Global Viral Safety Testing Revenue Market Share by Player (2020-2025)
3.2 Global Viral Safety Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Viral Safety Testing by Region
4.1 Viral Safety Testing Market Size by Region (2020-2025)
4.2 Global Viral Safety Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Viral Safety Testing Market Size Growth (2020-2025)
4.4 APAC Viral Safety Testing Market Size Growth (2020-2025)
4.5 Europe Viral Safety Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Viral Safety Testing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Viral Safety Testing Market Size by Country (2020-2025)
5.2 Americas Viral Safety Testing Market Size by Type (2020-2025)
5.3 Americas Viral Safety Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Safety Testing Market Size by Region (2020-2025)
6.2 APAC Viral Safety Testing Market Size by Type (2020-2025)
6.3 APAC Viral Safety Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Viral Safety Testing Market Size by Country (2020-2025)
7.2 Europe Viral Safety Testing Market Size by Type (2020-2025)
7.3 Europe Viral Safety Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Viral Safety Testing by Region (2020-2025)
8.2 Middle East & Africa Viral Safety Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Viral Safety Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Viral Safety Testing Market Forecast
10.1 Global Viral Safety Testing Forecast by Region (2026-2031)
10.1.1 Global Viral Safety Testing Forecast by Region (2026-2031)
10.1.2 Americas Viral Safety Testing Forecast
10.1.3 APAC Viral Safety Testing Forecast
10.1.4 Europe Viral Safety Testing Forecast
10.1.5 Middle East & Africa Viral Safety Testing Forecast
10.2 Americas Viral Safety Testing Forecast by Country (2026-2031)
10.2.1 United States Market Viral Safety Testing Forecast
10.2.2 Canada Market Viral Safety Testing Forecast
10.2.3 Mexico Market Viral Safety Testing Forecast
10.2.4 Brazil Market Viral Safety Testing Forecast
10.3 APAC Viral Safety Testing Forecast by Region (2026-2031)
10.3.1 China Viral Safety Testing Market Forecast
10.3.2 Japan Market Viral Safety Testing Forecast
10.3.3 Korea Market Viral Safety Testing Forecast
10.3.4 Southeast Asia Market Viral Safety Testing Forecast
10.3.5 India Market Viral Safety Testing Forecast
10.3.6 Australia Market Viral Safety Testing Forecast
10.4 Europe Viral Safety Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Viral Safety Testing Forecast
10.4.2 France Market Viral Safety Testing Forecast
10.4.3 UK Market Viral Safety Testing Forecast
10.4.4 Italy Market Viral Safety Testing Forecast
10.4.5 Russia Market Viral Safety Testing Forecast
10.5 Middle East & Africa Viral Safety Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Viral Safety Testing Forecast
10.5.2 South Africa Market Viral Safety Testing Forecast
10.5.3 Israel Market Viral Safety Testing Forecast
10.5.4 Turkey Market Viral Safety Testing Forecast
10.6 Global Viral Safety Testing Forecast by Type (2026-2031)
10.7 Global Viral Safety Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Viral Safety Testing Forecast
11 Key Players Analysis
11.1 Charles River
11.1.1 Charles River Company Information
11.1.2 Charles River Viral Safety Testing Product Offered
11.1.3 Charles River Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Charles River Main Business Overview
11.1.5 Charles River Latest Developments
11.2 Eurofins BioPharma
11.2.1 Eurofins BioPharma Company Information
11.2.2 Eurofins BioPharma Viral Safety Testing Product Offered
11.2.3 Eurofins BioPharma Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Eurofins BioPharma Main Business Overview
11.2.5 Eurofins BioPharma Latest Developments
11.3 Clean Cells
11.3.1 Clean Cells Company Information
11.3.2 Clean Cells Viral Safety Testing Product Offered
11.3.3 Clean Cells Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Clean Cells Main Business Overview
11.3.5 Clean Cells Latest Developments
11.4 Texcell
11.4.1 Texcell Company Information
11.4.2 Texcell Viral Safety Testing Product Offered
11.4.3 Texcell Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Texcell Main Business Overview
11.4.5 Texcell Latest Developments
11.5 Merck Millipore
11.5.1 Merck Millipore Company Information
11.5.2 Merck Millipore Viral Safety Testing Product Offered
11.5.3 Merck Millipore Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Merck Millipore Main Business Overview
11.5.5 Merck Millipore Latest Developments
11.6 Syngene
11.6.1 Syngene Company Information
11.6.2 Syngene Viral Safety Testing Product Offered
11.6.3 Syngene Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Syngene Main Business Overview
11.6.5 Syngene Latest Developments
11.7 CPHI Online
11.7.1 CPHI Online Company Information
11.7.2 CPHI Online Viral Safety Testing Product Offered
11.7.3 CPHI Online Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 CPHI Online Main Business Overview
11.7.5 CPHI Online Latest Developments
11.8 Nelson Labs
11.8.1 Nelson Labs Company Information
11.8.2 Nelson Labs Viral Safety Testing Product Offered
11.8.3 Nelson Labs Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Nelson Labs Main Business Overview
11.8.5 Nelson Labs Latest Developments
11.9 Sartorius Stedim BioOutsource Limited
11.9.1 Sartorius Stedim BioOutsource Limited Company Information
11.9.2 Sartorius Stedim BioOutsource Limited Viral Safety Testing Product Offered
11.9.3 Sartorius Stedim BioOutsource Limited Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Sartorius Stedim BioOutsource Limited Main Business Overview
11.9.5 Sartorius Stedim BioOutsource Limited Latest Developments
11.10 WuXi Biologics
11.10.1 WuXi Biologics Company Information
11.10.2 WuXi Biologics Viral Safety Testing Product Offered
11.10.3 WuXi Biologics Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 WuXi Biologics Main Business Overview
11.10.5 WuXi Biologics Latest Developments
11.11 ViSpot Co., Ltd.
11.11.1 ViSpot Co., Ltd. Company Information
11.11.2 ViSpot Co., Ltd. Viral Safety Testing Product Offered
11.11.3 ViSpot Co., Ltd. Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 ViSpot Co., Ltd. Main Business Overview
11.11.5 ViSpot Co., Ltd. Latest Developments
11.12 Syngene International Ltd.
11.12.1 Syngene International Ltd. Company Information
11.12.2 Syngene International Ltd. Viral Safety Testing Product Offered
11.12.3 Syngene International Ltd. Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Syngene International Ltd. Main Business Overview
11.12.5 Syngene International Ltd. Latest Developments
11.13 Laboratory Corporation of America Holdings
11.13.1 Laboratory Corporation of America Holdings Company Information
11.13.2 Laboratory Corporation of America Holdings Viral Safety Testing Product Offered
11.13.3 Laboratory Corporation of America Holdings Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Laboratory Corporation of America Holdings Main Business Overview
11.13.5 Laboratory Corporation of America Holdings Latest Developments
11.14 Creative Biogene
11.14.1 Creative Biogene Company Information
11.14.2 Creative Biogene Viral Safety Testing Product Offered
11.14.3 Creative Biogene Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Creative Biogene Main Business Overview
11.14.5 Creative Biogene Latest Developments
11.15 Asahi Kasei Corporation
11.15.1 Asahi Kasei Corporation Company Information
11.15.2 Asahi Kasei Corporation Viral Safety Testing Product Offered
11.15.3 Asahi Kasei Corporation Viral Safety Testing Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Asahi Kasei Corporation Main Business Overview
11.15.5 Asahi Kasei Corporation Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂